I saw that post from Michael Thurn. While I think the content is fantastic it left me scratching my head somewhat.
Why is he posting information about other companies now that he is MD of Pharmaust?
Why hasn't he convened an investor webinar to meet/greet shareholders and allow him to share his vision with us? I'm sure there are quite a few of us who have some important questions we want answered from the Company.
BTW - here is the link for the Macquarie University webinar.
Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-332
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.5¢ | $194.1K | 889.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4996 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 114999 | 4 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |